Posttraumatic Stress Disorder (PTSD) is a mental disorder that may occur after someone experiences a traumatic event. Between 10-20% of patients may develop PTSD in response to the traumatic experience of myocardial infarction (MI). PTSD is associated with impaired quality of life, social functioning, and high economic burden to the society. Posttraumatic stress attributable to MI has also been shown to be predictive of poor cardiovascular prognosis, whereby this link might relate to several atherothrombotic processes. Therefore the prevention of PTSD after MI is of high relevance. Guidelines have been published for early interventions to prevent the development of posttraumatic stress after different types of trauma but not in terms of acute MI as a traumatic event. The overarching aim of the planned trial is to test whether a minimal behavioral intervention performed shortly after acute MI in patients at a high risk to develop PTSD and in the setting of a coronary care unit reduces the development of posttraumatic stress. The primary hypothesis is that posttraumatic stress levels at the 3-month follow-up will be at least 20% lower in the intervention group than in the control group, and that this effect will last up to 12 months after the intervention. The secondary hypothesis is that the intervention group will show better psychosocial functioning, and a more favourable cardiometabolic biomarker profile than the control group 3 and 12 month after the intervention.
Background Posttraumatic Stress Disorder (PTSD) is a mental disorder that may occur after someone experiences a traumatic event. Between 10-20% of patients may develop PTSD in response to the traumatic experience of myocardial infarction (MI). Sociodemographic and psychosocial variables, including perceived distress during MI, have been identified as "risk factors" for the development of posttraumatic stress in the aftermath of MI. PTSD is associated with impaired quality of life, social functioning, and high economic burden to the society. Posttraumatic stress attributable to MI has also been shown to be predictive of poor cardiovascular prognosis, whereby this link might relate to atherothrombotic processes like endothelial dysfunction, dyslipidemia, inflammation, and coagulation. Therefore the prevention of PTSD after MI is of high relevance. Guidelines have been published for early interventions to prevent the development of posttraumatic stress after different types of trauma. A recent systematic review and meta-analysis on randomized controlled trials of early psychological interventions designed to prevent symptoms of PTSD found a benefit, but only if treatment was provided to symptomatic individuals and trauma-focused. The impact of such an intervention on posttraumatic stress in response to a myocardial infarction has not been assessed so far. The planned project is the first to test, if the development of posttraumatic stress can successfully be prevented in MI patients at high risk to develop PTSD through a minimal behavioral intervention that is feasible. Objective Primary aim: The overarching aim of the planned project is to investigate in a randomized-controlled trial whether a minimal (single counseling session of 45 minutes plus an information booklet) and early-on (within 48 hours after myocardial infarction) administered behavioral intervention reduces the development of clinician-rated posttraumatic stress levels attributable to MI in patients at a high risk to develop clinically relevant levels of posttraumatic stress. Secondary aim: A further aim is to investigate whether the behavioral intervention improves psychosocial functioning and favorably affects cardiometabolic risk markers. Methods Patients considered to be at "high risk" to develop posttraumatic stress will be randomized to one single counseling session of 45 minutes (either targeting specific MI-triggered traumatic reactions or more general information about the role of psychological stress in coronary heart disease). The session will be performed by the study therapist in the coronary care unit within 48 hours after the patient has reached stable circulatory condition. Each patient will additionally receive written study material in the form of an information booklet. Medical variables, sociodemographic factors and cardiometabolic biomarkers will also be determined. At 3-month and 12-month follow-up each patient will be assessed for interviewer-rated posttraumatic stress levels, psychosocial functioning, and biomarkers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
190
The minimal behavioral intervention consists of one single counseling session of 45 minutes that targets specific MI-triggered traumatic reactions. The focus of the intervention is an educational and resource-oriented approach targeting individual patient resources and cognitive (re)structuring.
The control intervention consists of one single counseling session of 45 minutes that targets more general information about the role of psychological stress in coronary heart disease. Any terminology related to "trauma" will be completely avoided.
Dep. of General Internal Medicine, Bern University Hospital
Bern, Canton of Bern, Switzerland
Clinician-rated posttraumatic stress level
Measured by Clinician-Administered PTSD Scale (CAPS) (German version)
Time frame: 3 months
Clinician-rated posttraumatic stress level
Measured by Clinician-Administered PTSD Scale (CAPS) (German version)
Time frame: 12 months
Self-rated Posttraumatic Stress
Measured by Posttraumatic Diagnostic Scale (PDS) (German version); The term "event" will be replaced with the term "heart attack" to assess MI-specific posttraumatic stress.
Time frame: 3 and 12 months
Quality of Life
Measured by EuroQol group 5 dimension questionnaire (EQ-5D) (German version)
Time frame: 3 and 12 months
Depressive Symptoms
Measured by Beck Depression Inventory (BDI) (German version)
Time frame: 3 and 12 months
Overall psychological distress
Measured by self-rated symptom checklist-9 (SCL-9-K) (German version)
Time frame: 3 and 12 months
Positive and Negative Affect
Measured by 20-item Global Mood Scale (GMS) (German version)
Time frame: 3 and 12 months
Time duration to recurrence at previous job (incl. part-time)
Time frame: 3 and 12 months
Time duration to recurrence at household to extent at least 50%
Time frame: 3 and 12 months
Vitality status
Measured if alive or deceased (with cause of death)
Time frame: 3 and 12 months
Recurrent Hospitalisations
Measured: number and cause
Time frame: 3 and 12 months
Recurrent Doctor Visits - general practitioner as well as specialist
Measured: number and cause
Time frame: 3 and 12 months
Inflammation Markers
Measured by high sensitive C-reactive protein, Interleukin-6, Tumor necrosis factor alpha, Interleukin-4
Time frame: 3 and 12 months
Hemostasis Markers
Measured by Fibrinogen, D-dimer, von Willebrand factor (antigen)
Time frame: 3 and 12 months
Metabolic Factors
Measured by total cholesterol, Low-density lipoprotein-Cholesterol, High-density lipoprotein-Cholesterol, triglycerides, glucose, HbA1c
Time frame: 3 and 12 months
Anthropometric measurements
Measured by weight, height, body mass index (kg/m2), waist circumference, hip circumference, waist-to-hip ratio
Time frame: 3 and 12 months
Resting hemodynamics
Measured by heart rate, systolic blood pressure, diastolic blood pressure
Time frame: 3 and 12 months
Heart rate variability
Measured by total power, high frequency power, low frequency power, low-to-high frequency power ratio
Time frame: 3 and 12 months
Stress Hormones
Measured by plasma cortisol, norepinephrine, epinephrine
Time frame: 3 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.